Status:

ACTIVE_NOT_RECRUITING

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Gynecologic Cancer

Ovarian Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.

Detailed Description

Primary goals of this project are: Objective 1: Phase 1: To collect feedback from patients on CCI online and to assess patient's evaluation of CCI online. Objective 2: Phase 1: To examine the feasib...

Eligibility Criteria

Inclusion

  • Diagnosed with any stage of primary ovarian cancer, primary peritoneal cancer, or primary fallopian tube cancer or experienced a recurrence in the past 5 years;
  • Diagnosed with High Grade Stage 2, any grade Stage 3 or higher endometrial cancer or experienced a recurrence in the past 5 years;
  • Diagnosed with Stage 2 or higher cervical cancer or experienced a recurrence within the past 5 years;
  • Diagnosed with any stage Uterine Cancer (both Sarcoma and carcinosarcoma) or experienced a recurrence in the past 5 years;
  • At the time of recruitment the patient has received chemotherapy or radiation in the past 5 years, or is less than 5 years post-cancer surgery;
  • At the time of recruitment, a Karnofsky Performance Status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) (80) score of 0 or 1;
  • 18 years of age or older;
  • English speaking;
  • Has internet access, able to view the online intervention sessions and attend telephone or video/telehealth chats to discuss the session content and provide feedback;
  • Must give informed consent within 5 years of diagnosis.

Exclusion

  • \-

Key Trial Info

Start Date :

July 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05220033

Start Date

July 14 2020

End Date

December 1 2026

Last Update

December 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08901